Cargando…

A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study

Background: Cardiovascular disease (CVD) is a major, worldwide problem that remains the dominant cause of premature mortality in the world, and increasing rates of dysglycaemia are a major contributor to its development. The aim of this study was to investigate the cardiometabolic profile among pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Chlabicz, Małgorzata, Jamiołkowski, Jacek, Łaguna, Wojciech, Sowa, Paweł, Paniczko, Marlena, Łapińska, Magda, Szpakowicz, Małgorzata, Drobek, Natalia, Raczkowski, Andrzej, Kamiński, Karol A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069041/
https://www.ncbi.nlm.nih.gov/pubmed/33918620
http://dx.doi.org/10.3390/jcm10081584
_version_ 1783683144221720576
author Chlabicz, Małgorzata
Jamiołkowski, Jacek
Łaguna, Wojciech
Sowa, Paweł
Paniczko, Marlena
Łapińska, Magda
Szpakowicz, Małgorzata
Drobek, Natalia
Raczkowski, Andrzej
Kamiński, Karol A.
author_facet Chlabicz, Małgorzata
Jamiołkowski, Jacek
Łaguna, Wojciech
Sowa, Paweł
Paniczko, Marlena
Łapińska, Magda
Szpakowicz, Małgorzata
Drobek, Natalia
Raczkowski, Andrzej
Kamiński, Karol A.
author_sort Chlabicz, Małgorzata
collection PubMed
description Background: Cardiovascular disease (CVD) is a major, worldwide problem that remains the dominant cause of premature mortality in the world, and increasing rates of dysglycaemia are a major contributor to its development. The aim of this study was to investigate the cardiometabolic profile among patients in particular cardiovascular risk classes, and to estimate their long term CV risk. Methods: A total of 931 individuals aged 20–79 were included. The study population was divided into CV risk classes according to the latest European Society of Cardiology recommendations. Results: Most of the analyzed anthropometric, body composition and laboratory parameters did not differ between the moderate and high CV risk participants. Interestingly, estimating the lifetime risk of myocardial infarction, stroke or CV death, using the LIFEtime-perspective model for individualizing CardioVascular Disease prevention strategies in apparently healthy people, yielded similar results in moderate and high CV risk classes. Conclusion: The participants who belonged to moderate and high CV risk classes had very similar unfavorable cardiometabolic profiles, which may result in similar lifetime CV risk. This may imply the need for more aggressive pharmacological and non-pharmacological management of CV risk factors in the moderate CV risk population, who are often unaware of their situation. New prospective population studies are necessary to establish the true cardiovascular risk profiles in a changing society.
format Online
Article
Text
id pubmed-8069041
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80690412021-04-26 A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study Chlabicz, Małgorzata Jamiołkowski, Jacek Łaguna, Wojciech Sowa, Paweł Paniczko, Marlena Łapińska, Magda Szpakowicz, Małgorzata Drobek, Natalia Raczkowski, Andrzej Kamiński, Karol A. J Clin Med Article Background: Cardiovascular disease (CVD) is a major, worldwide problem that remains the dominant cause of premature mortality in the world, and increasing rates of dysglycaemia are a major contributor to its development. The aim of this study was to investigate the cardiometabolic profile among patients in particular cardiovascular risk classes, and to estimate their long term CV risk. Methods: A total of 931 individuals aged 20–79 were included. The study population was divided into CV risk classes according to the latest European Society of Cardiology recommendations. Results: Most of the analyzed anthropometric, body composition and laboratory parameters did not differ between the moderate and high CV risk participants. Interestingly, estimating the lifetime risk of myocardial infarction, stroke or CV death, using the LIFEtime-perspective model for individualizing CardioVascular Disease prevention strategies in apparently healthy people, yielded similar results in moderate and high CV risk classes. Conclusion: The participants who belonged to moderate and high CV risk classes had very similar unfavorable cardiometabolic profiles, which may result in similar lifetime CV risk. This may imply the need for more aggressive pharmacological and non-pharmacological management of CV risk factors in the moderate CV risk population, who are often unaware of their situation. New prospective population studies are necessary to establish the true cardiovascular risk profiles in a changing society. MDPI 2021-04-09 /pmc/articles/PMC8069041/ /pubmed/33918620 http://dx.doi.org/10.3390/jcm10081584 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chlabicz, Małgorzata
Jamiołkowski, Jacek
Łaguna, Wojciech
Sowa, Paweł
Paniczko, Marlena
Łapińska, Magda
Szpakowicz, Małgorzata
Drobek, Natalia
Raczkowski, Andrzej
Kamiński, Karol A.
A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study
title A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study
title_full A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study
title_fullStr A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study
title_full_unstemmed A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study
title_short A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study
title_sort similar lifetime cv risk and a similar cardiometabolic profile in the moderate and high cardiovascular risk populations: a population-based study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069041/
https://www.ncbi.nlm.nih.gov/pubmed/33918620
http://dx.doi.org/10.3390/jcm10081584
work_keys_str_mv AT chlabiczmałgorzata asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT jamiołkowskijacek asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT łagunawojciech asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT sowapaweł asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT paniczkomarlena asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT łapinskamagda asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT szpakowiczmałgorzata asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT drobeknatalia asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT raczkowskiandrzej asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT kaminskikarola asimilarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT chlabiczmałgorzata similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT jamiołkowskijacek similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT łagunawojciech similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT sowapaweł similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT paniczkomarlena similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT łapinskamagda similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT szpakowiczmałgorzata similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT drobeknatalia similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT raczkowskiandrzej similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy
AT kaminskikarola similarlifetimecvriskandasimilarcardiometabolicprofileinthemoderateandhighcardiovascularriskpopulationsapopulationbasedstudy